Related Experiment Videos
Movement disorders associated with neuroleptic treatment
1Department of Psychiatry and Biobehavioral Science, University of California at Los Angeles School of Medicine, USA.
The Journal of Clinical Psychiatry
|October 5, 2001
Summary
Neuroleptic-induced movement disorders, known as extrapyramidal side effects (EPS), include acute and tardive syndromes. Newer atypical antipsychotics offer a safer alternative to conventional neuroleptics, with a reduced risk of causing these movement disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Neuroleptic medications are widely used for psychiatric disorders.
- These drugs can cause movement disorders, termed extrapyramidal side effects (EPS).
- EPS are broadly categorized into acute and tardive syndromes.
Purpose of the Study:
- To review the classification and characteristics of neuroleptic-induced movement disorders.
- To compare the EPS profiles of conventional and atypical antipsychotic medications.
Main Methods:
- Literature review of neuroleptic-induced movement disorders.
- Analysis of clinical data comparing conventional and atypical antipsychotics regarding EPS incidence.
Main Results:
- Acute EPS include parkinsonism, dystonia, and akathisia.
- Conventional neuroleptics are frequently associated with EPS.
- Atypical antipsychotics demonstrate a lower propensity for inducing EPS compared to conventional agents.
Conclusions:
- Neuroleptic-induced movement disorders represent a significant clinical challenge.
- Atypical antipsychotics present a more favorable risk-benefit profile for managing psychiatric conditions due to reduced EPS.
- Further research into optimizing treatment strategies for psychiatric disorders with minimal motor side effects is warranted.